Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy
The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.
Trial Details
- NCT ID
- NCT06778954
- Phase
- NA
- Sponsor
- Gangnam Severance Hospital
- Status
- RECRUITING
- Cancer Type
- Gastric Cancer
- Interventions
- Arm I (Peritoneal application group)
- Arm II (Subcutaneous injection group)
- Locations (sample)
- Seoul, South Korea|37.566,126.9784
Key Eligibility Criteria
- Patients with a histologically confirmed diagnosis of gastric adenocarcinoma prior to surgery.
- Patients who have undergone a complete surgical resection (R0 resection).
- Patients with an ASA (American Society of Anesthesiologists) score of 3 or below.
- Patients aged 20 years or older.
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Gastric Cancer Trials on Trialify →